Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
153,881,229
-
Number of holders
-
56
-
Total 13F shares, excl. options
-
55,856,035
-
Shares change
-
-1,760,173
-
Total reported value, excl. options
-
$42,041,103
-
Value change
-
-$1,434,569
-
Put/Call ratio
-
45%
-
Number of buys
-
17
-
Number of sells
-
-31
-
Price
-
$0.7550
Significant Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q1 2025
68 filings reported holding ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 as of Q1 2025.
Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) has 56 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55,856,035 shares
of 153,881,229 outstanding shares and own 36% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (11,447,140 shares), TANG CAPITAL MANAGEMENT LLC (8,223,612 shares), RA CAPITAL MANAGEMENT, L.P. (7,541,000 shares), GOLDMAN SACHS GROUP INC (3,816,556 shares), VANGUARD GROUP INC (3,205,882 shares), Carlyle Group Inc. (2,948,718 shares), Aquilo Capital Management, LLC (2,456,194 shares), ACADIAN ASSET MANAGEMENT LLC (2,039,324 shares), CITADEL ADVISORS LLC (1,248,711 shares), and Blackstone Inc. (1,236,453 shares).
This table shows the top 56 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.